ConductScience.org, home

Paper40539416

Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks.

Milà-Alomà M and 27 others. Ann Neurol, 2025. Cited by 38 papers, by iCite.

Cite this record

ConductScience Library. Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks. Papers, record 40539416. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40539416

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks.
PubMed
Journal
Ann Neurol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
9.9, provisional
iCite
Revised in PubMed
2026-05-28
PubMed

Authors28

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Milà-Alomà MMarta
2Tosun DDuygu
3Schindler SESuzanne E
4Hausle IIsabella
5Petersen KKKellen K
6Li YYan
7Dage JLJeffrey L
8Du-Cuny LLei
9Saad ZSZiad S
10Saef BBenjamin
11Triana-Baltzer GGallen
12Raunig DLDavid L
13Coomaraswamy JJanaky
14Baratta MMichael
15Meyers EAEmily A
16Mordashova YYulia
17Rubel CECarrie E
18Ferber KKyle
19Kolb HHartmuth
20Ashton NJNicholas J

Source PubMed

See all 28 authorsDownload CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
tau ProteinsMajor topic
Alzheimer DiseaseMajor topic
Amyloid beta-PeptidesMajor topic
Humans
Male
Female
Positron-Emission Tomography
Biomarkers
Aged
Aged, 80 and over
Disease Progression
Longitudinal Studies
Middle Aged
Peptide Fragments
Neurofilament Proteins
Glial Fibrillary Acidic Protein
Time Factors

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
a public-private partnership managed by the Foundation for the National Institutes of HealthBiomarkers Consortium, Plasma Aβ and Phosphorylated Tau as Predictors of Amyloid and Tau Positivity in Alzheimer's Disease ProjectPubMedPubMed
U24 AG021886NIA NIH HHSUnited StatesU24AG021886PubMed and NIHNIH RePORTER
R01 AG070941NIA NIH HHSUnited StatesR01AG070941PubMed and NIHNIH RePORTER
R01AG070941NIA NIH HHSUnited StatesR01AG070941PubMed and NIHNIH RePORTER
U19 AG024904NIA NIH HHSUnited StatesU19AG024904PubMed and NIHNIH RePORTER
AARF-23-1141384Alzheimer's AssociationUnited StatesPubMedPubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of39574864

Source PubMed

Download CSV of comments and corrections

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135907254Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment.JAMA Neurol2022https://conductscience.org/library/papers/35907254PubMed
238491912Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and Aβ42/40 ratio to identify presence of brain amyloid.Alzheimers Dement2024https://conductscience.org/library/papers/38491912PubMed
334661615Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.JAMA Neurol2021https://conductscience.org/library/papers/34661615PubMed
439255800Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer's disease.Med2024https://conductscience.org/library/papers/39255800PubMed
536087307Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.Brain2023https://conductscience.org/library/papers/36087307PubMed
638400792Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset.Ann Neurol2024https://conductscience.org/library/papers/38400792PubMed
737248300Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's disease.Nat Med2023https://conductscience.org/library/papers/37248300PubMed
88232972The Clinical Dementia Rating (CDR): current version and scoring rules.Neurology1993https://conductscience.org/library/papers/8232972PubMed
934504028Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET.Neurology2021https://conductscience.org/library/papers/34504028PubMed
1031371569High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis.Neurology2019https://conductscience.org/library/papers/31371569PubMed
1136987840Mitigating the Associations of Kidney Dysfunction With Blood Biomarkers of Alzheimer Disease by Using Phosphorylated Tau to Total Tau Ratios.JAMA Neurol2023https://conductscience.org/library/papers/36987840PubMed
1237216632Longitudinal changes in Alzheimer's-related plasma biomarkers and brain amyloid.Alzheimers Dement2023https://conductscience.org/library/papers/37216632PubMed
1327931796The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement.Alzheimers Dement2017https://conductscience.org/library/papers/27931796PubMed
1434542571Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease.JAMA Neurol2021https://conductscience.org/library/papers/34542571PubMed
1526194311The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015.Alzheimers Dement2015https://conductscience.org/library/papers/26194311PubMed
1630304397Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers.Brain2018https://conductscience.org/library/papers/30304397PubMed
1730847382Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies.Alzheimers Dement (Amst)2019https://conductscience.org/library/papers/30847382PubMed
1835678397Alzheimer Disease.Continuum (Minneap Minn)2022https://conductscience.org/library/papers/35678397PubMed
1935856240Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts.Brain2022https://conductscience.org/library/papers/35856240PubMed
2036508198Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography.JAMA Neurol2023https://conductscience.org/library/papers/36508198PubMed

See all 56 referencesDownload CSV of references

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
42923225Noninvasive diagnosis of Alzheimer's disease: a review of emerging biomarkers and multimodal approaches.Front Cell Dev Biol2026https://conductscience.org/library/papers/42923225PubMed
42889489Comparison of brain-derived versus conventional pTau biomarkers in CSF and plasma for detecting Alzheimer's disease.Brain Commun2026https://conductscience.org/library/papers/42889489PubMed
42798750Real-world implementation of lecanemab in Alzheimer's disease: A Japanese cohort.Alzheimers Dement (Amst)2026https://conductscience.org/library/papers/42798750PubMed
42768846Do amyloid trajectories reach a ceiling? Evidence from iterative approximation and simulation.Alzheimers Dement2026https://conductscience.org/library/papers/42768846PubMed
42719047Comparative analyses of Alzheimer's disease blood biomarkers and cognitive domains.Alzheimers Dement (Amst)2026https://conductscience.org/library/papers/42719047PubMed
42683384From amyloid PET to plasma biomarkers: A multimodal imaging framework for early diagnosis and staging of Alzheimer's disease.Alzheimers Dement (Amst)2026https://conductscience.org/library/papers/42683384PubMed
42638803Neuroimaging Epicenters as Vulnerable Nodes in Plasma p-tau217/Aβ42-Positive Alzheimer's Disease.Research (Wash D C)2026https://conductscience.org/library/papers/42638803PubMed
42637536Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.J Neurol Neurosurg Psychiatry2026https://conductscience.org/library/papers/42637536PubMed
42601919Amyloid-β modulates APOE ε4 effects on cognition but not on targeted structural or functional connectivity measures over 2 years in pre-dementia adults.Front Aging Neurosci2026https://conductscience.org/library/papers/42601919PubMed
42597443Toward personalized medicine in AD/ADRD through genetic-exposome dementia risk assessments.NPJ Dement2026https://conductscience.org/library/papers/42597443PubMed
42535261Exploring longitudinal relationships among Alzheimer's disease biomarkers.Alzheimers Dement2026https://conductscience.org/library/papers/42535261PubMed
42523318Biomarker Variability Limits Individualized Amyloid Time Estimation in Alzheimer Disease.bioRxiv2026https://conductscience.org/library/papers/42523318PubMed
42477212Patient-Derived PSEN1 Cerebral Organoids Revealed Parallel Development of Amyloid-β Accumulation and Network Dysfunction.Cell Mol Neurobiol2026https://conductscience.org/library/papers/42477212PubMed
42425064Recent advances in Alzheimer's disease: From molecular mechanisms to therapeutic strategies.Cell2026https://conductscience.org/library/papers/42425064PubMed
42369495Multi-domain AD risk burden and plasma biomarkers in cognitively unimpaired adults.medRxiv2026https://conductscience.org/library/papers/42369495PubMed
42323462Plasma p-Tau217 and Aβ42/Aβ40 mediate the association between minimal depressive symptoms and cognitive impairment.J Neurol2026https://conductscience.org/library/papers/42323462PubMed
42309987Contributions of the Alzheimer's Disease Neuroimaging Initiative to advancing AD research: a targeted review of recent publications.Alzheimers Dement2026https://conductscience.org/library/papers/42309987PubMed
42145632Comparative analyses of Alzheimer's disease blood biomarkers and cognitive domains.medRxiv2026https://conductscience.org/library/papers/42145632PubMed
42021299Plasma biomarker trajectories across Alzheimer's clinical onset: a 17-year prospective study.Alzheimers Res Ther2026https://conductscience.org/library/papers/42021299PubMed
42010230Brain, benefit, or burden? Revisiting statins and cognitive function in older adults.Geroscience2026https://conductscience.org/library/papers/42010230PubMed

See all 39 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
GFAP2670PubTator's text mininghttps://conductscience.org/library/genes/2670NCBI Gene
MAPT4137PubTator's text mininghttps://conductscience.org/library/genes/4137NCBI Gene
NEFL4747PubTator's text mininghttps://conductscience.org/library/genes/4747NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40539416

GET https://conductscience.org/api/papers/v1/40539416/authors?page=2